Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000596723 | SCV000705729 | uncertain significance | not provided | 2018-08-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000618168 | SCV000735612 | likely benign | Cardiovascular phenotype | 2016-11-10 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV001089168 | SCV001005940 | likely benign | Alagille syndrome due to a JAG1 point mutation | 2024-01-06 | criteria provided, single submitter | clinical testing |